WallStreetZenWallStreetZen

NASDAQ: BPMC
Blueprint Medicines Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BPMC

Based on 12 analysts offering 12 month price targets for Blueprint Medicines Corp

Min Forecast
$88.00+4.54%
Avg Forecast
$127.75+51.76%
Max Forecast
$151.00+79.38%

Should I buy or sell BPMC stock?

Based on 12 analysts offering ratings for Blueprint Medicines Corp.

Buy
Strong Buy
4 analysts 33.33%
Buy
5 analysts 41.67%
Hold
3 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BPMC's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BPMC as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BPMC stock forecasts and price targets.

BPMC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-16
lockedlocked$00.00+00.00%2025-04-08
lockedlocked$00.00+00.00%2025-03-20
lockedlocked$00.00+00.00%2025-03-17
lockedlocked$00.00+00.00%2025-03-07
Citizens Capital Markets
Bottom 4%
4
BuyReiterates$125.00+48.49%2025-03-03
HC Wainwright & Co.
Bottom 2%
2
BuyReiterates$135.00+60.37%2025-02-14
JP Morgan
Bottom 6%
6
Strong BuyMaintains$129.00+53.24%2025-02-04
Piper Sandler
Bottom 5%
5
HoldMaintains$119.00+41.36%2025-01-27
Stephens & Co.
Bottom 2%
2
Strong BuyReiterates$140.00+66.31%2025-01-02

1 of 2

Forecast return on equity

Is BPMC forecast to generate an efficient return?

Company
121.96%
Industry
153.19%
Market
81.87%
BPMC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BPMC forecast to generate an efficient return on assets?

Company
30.87%
Industry
36.07%
BPMC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BPMC earnings per share forecast

What is BPMC's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
-$1.00
Avg 2 year Forecast
$0.60
Avg 3 year Forecast
$2.93

BPMC revenue forecast

What is BPMC's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$729.1M+43.29%
Avg 2 year Forecast
$955.7M+87.82%
Avg 3 year Forecast
$1.2B+134.33%
BPMC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BPMC revenue growth forecast

How is BPMC forecast to perform vs Biotechnology companies and vs the US market?

Company
32.74%
Industry
65.48%
Market
10.37%
BPMC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BPMC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BPMC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BPMC$84.18$127.75+51.76%Buy
SRPT$55.23$129.39+134.27%Buy
TLX$16.21$22.00+35.72%Strong Buy
VRNA$60.07$70.00+16.53%Strong Buy
AXSM$103.00$175.71+70.60%Strong Buy
View Top Biotech Stocks

Blueprint Medicines Stock Forecast FAQ

Is Blueprint Medicines Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NASDAQ: BPMC) stock is to Buy BPMC stock.

Out of 12 analysts, 4 (33.33%) are recommending BPMC as a Strong Buy, 5 (41.67%) are recommending BPMC as a Buy, 3 (25%) are recommending BPMC as a Hold, 0 (0%) are recommending BPMC as a Sell, and 0 (0%) are recommending BPMC as a Strong Sell.

If you're new to stock investing, here's how to buy Blueprint Medicines stock.

What is BPMC's earnings growth forecast for 2025-2027?

(NASDAQ: BPMC) Blueprint Medicines's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Blueprint Medicines's earnings in 2025 is -$67,089,000.On average, 12 Wall Street analysts forecast BPMC's earnings for 2025 to be -$64,116,901, with the lowest BPMC earnings forecast at -$143,149,465, and the highest BPMC earnings forecast at $53,681,049. On average, 12 Wall Street analysts forecast BPMC's earnings for 2026 to be $38,183,842, with the lowest BPMC earnings forecast at -$95,219,956, and the highest BPMC earnings forecast at $185,327,432.

In 2027, BPMC is forecast to generate $187,429,940 in earnings, with the lowest earnings forecast at $25,562,404 and the highest earnings forecast at $394,300,088.

What is BPMC's revenue growth forecast for 2025-2027?

(NASDAQ: BPMC) Blueprint Medicines's forecast annual revenue growth rate of 32.74% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Blueprint Medicines's revenue in 2025 is $508,824,000.On average, 10 Wall Street analysts forecast BPMC's revenue for 2025 to be $46,595,086,834, with the lowest BPMC revenue forecast at $44,197,397,208, and the highest BPMC revenue forecast at $52,018,853,894. On average, 10 Wall Street analysts forecast BPMC's revenue for 2026 to be $61,072,098,942, with the lowest BPMC revenue forecast at $55,108,709,526, and the highest BPMC revenue forecast at $64,902,944,772.

In 2027, BPMC is forecast to generate $76,197,437,532 in revenue, with the lowest revenue forecast at $72,547,381,807 and the highest revenue forecast at $82,754,449,884.

What is BPMC's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: BPMC) forecast ROA is 30.87%, which is lower than the forecast US Biotechnology industry average of 36.07%.

What is BPMC's Price Target?

According to 12 Wall Street analysts that have issued a 1 year BPMC price target, the average BPMC price target is $127.75, with the highest BPMC stock price forecast at $151.00 and the lowest BPMC stock price forecast at $88.00.

On average, Wall Street analysts predict that Blueprint Medicines's share price could reach $127.75 by Apr 16, 2026. The average Blueprint Medicines stock price prediction forecasts a potential upside of 51.76% from the current BPMC share price of $84.18.

What is BPMC's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BPMC) Blueprint Medicines's current Earnings Per Share (EPS) is -$1.07. On average, analysts forecast that BPMC's EPS will be -$1.00 for 2025, with the lowest EPS forecast at -$2.24, and the highest EPS forecast at $0.84. On average, analysts forecast that BPMC's EPS will be $0.60 for 2026, with the lowest EPS forecast at -$1.49, and the highest EPS forecast at $2.90. In 2027, BPMC's EPS is forecast to hit $2.93 (min: $0.40, max: $6.17).

What is BPMC's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: BPMC) forecast ROE is 121.96%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.